Bring Context to the Patient Journey With MapEnhance
Get the most comprehensive and complete view of the patient journey by layering multiple specialty datasets onto Komodo’s industry-leading Healthcare Map
Streamline Data Management
Access highly curated, exclusive data sources via a single contract, eliminating the need to identify, vet, contract, and manage multiple data vendors.
The MapEnhance Advantage
Accelerate speed to insights and receive a pre-integrated, fit-for-purpose dataset on delivery.
Comprehensive
Start with our foundation of provider- and payer-complete Mx claims and retail, specialty, and PBM Rx claims
Rich
Easily access and layer specialty data sources to obtain context and gain confidence in your data-driven decisions
Linkable
Connect the Healthcare Map to additional proprietary sources via commonly used de-identified tokens
MapEnhance Gives You More
MapEnhance™ builds on Komodo’s unmatched data foundation to bring new depth to patient journeys, enabling you to obtain answers that were previously out of reach.
Komodo Data Enhancements
Our high-fidelity specialty data products are rigorously de-duplicated, cleaned, formatted, and standardized by our skilled data scientists. These include lab, clinical encounters (EHR/EMR), race and ethnicity, mortality, and more.
Partner Data Enhancements
Additionally, we offer specialized and proprietary data assets such as genomics, oncology EMR, and more to enhance any patient cohort within the Healthcare Map.
MapEnhance in Action
Replace the fragmentation of marketplace or aggregator datasets with Komodo’s MapEnhance. One contract gives you multidimensional insights and greater patient journey contextualization.
Commercial
Refine patient segmentation for targeted oncology treatment by integrating biomarker, demographics, and claims data.
Clinical Development
Enhance understanding of patient journeys across races and ethnicities to inform clinical trial strategy and inclusion/exclusion criteria.
HEOR
Perform a real-world evaluation of progression-free survival following initiation of an oncology therapy.